| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | -0.38 | 0.03 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.33 | 2e-07 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.3 | 0.08 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.3 | 1e-06 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.3 | 0.09 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.29 | 2e-06 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.28 | 4e-05 |
| mRNA | PD-0332991 | FIMM | pan-cancer | AAC | -0.26 | 0.1 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.26 | 0.2 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | -0.25 | 0.004 |